Kimball Electronics, Inc.

Kimball Electronics, Inc. (KE) Market Cap

Kimball Electronics, Inc. has a market capitalization of $587.5M.

Price: $24.43

-1.92 (-7.29%)

Market Cap: 587.52M

NASDAQ · time unavailable

CEO: Richard D. Phillips

Sector: Industrials

Industry: Electrical Equipment & Parts

IPO Date: 2014-11-03

Website: https://www.kimballelectronics.com

Kimball Electronics, Inc. (KE) - Company Information

Market Cap: 587.52M|Sector: Industrials

Company Profile

Kimball Electronics, Inc. provides contract electronics manufacturing services and diversified manufacturing services to customers in the automotive, medical, industrial, and public safety end markets. The company's manufacturing services include design services and support, supply chain services and support, and rapid prototyping and product introduction support services, as well as product design, and process validation and qualification services. Its manufacturing services also comprise industrialization and automation of manufacturing processes; reliability testing, including testing of products under a series of environmental conditions; production and testing of printed circuit board assemblies; assembly, production, and packaging of medical devices and disposables, and other non-electronic products; drug delivery devices and solutions with and without electronics; design engineering and manufacturing of automation equipment, test and inspection equipment, and precision molded plastics; software design services; and product life cycle management services. The company operates in the United States, China, Mexico, Poland, Romania, Thailand, and Vietnam. Kimball Electronics, Inc. was founded in 1961 and is headquartered in Jasper, Indiana.

Analyst Sentiment

83%
Strong Buy

From 3 Active Polls

1Y Forecast: $26.00

▲ +6.4% Potential Upside

Consensus Target Metrics

Low Bound

$20

Median

$26

High Bound

$32

Average

$26

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$26.00
▲ +6.43% Upside
Low Target
$20.00
-18% Risk
Median Target
$26.00
6% Mid
High Target
$32.00
31% Max
Consensus
Buy
3 / 5 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)588580685735472407466462540
Enterprise Value ($M)683675760796530534616632757
Price to Earnings Ratio (P/E)22.9725.3447.0518.2117.9426.6433.9336.6517.91
Price/Earnings-to-Growth Ratio (PEG)7.4311.465.5314.86
Price to Sales Ratio (P/S)0.411.642.012.011.241.091.301.241.26
Price to Book Ratio (P/B)1.031.001.181.270.830.740.870.841.00
Price to Free Cash Flow Ratio (P/FCF)7.011260.1539.23-293.246.9015.1020.2914.4013.71
Enterprise Value to Sales (EV/Sales)1.912.232.181.391.421.721.691.76
Enterprise Value to EBITDA (EV/EBITDA)7.8231.5541.3835.4721.1527.7436.7437.4426.71
Debt to Equity Ratio1.090.310.270.240.260.330.380.450.55
⚠️

Valuation Model Suspended

API Payload Error: Inverted or negative baseline Free Cash Flow margin detected (-0.0%).

Troubleshooting Notice: The upstream financial data supplier has uploaded corrupted or inverted baseline metrics for KE. The server sandbox cannot calculate an intrinsic value path from negative cash generation baselines.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

```html

📘 KIMBALL ELECTRONICS INC (KE) — Investment Overview

🧩 Business Model Overview

Kimball Electronics (KE) operates as an electronics manufacturing services (EMS) provider, offering end-to-end production support for complex electronic products. The value chain typically spans:

  • Program development support: engineering collaboration during design-for-manufacturing (DFM), prototyping, and new product introduction (NPI).
  • Manufacturing and assembly: building electronic components and systems through PCB-related processes, advanced assembly, integration, testing, and “box-build” level work where required by customer specifications.
  • Lifecycle support: sustaining production once programs ramp, plus ongoing quality, testing, and documentation requirements that customers depend on for regulatory and operational continuity.

Customer stickiness in EMS is driven less by “brand” and more by qualification processes, quality history, and the operational cost of switching suppliers once a product is in production.

💰 Revenue Streams & Monetisation Model

KE monetizes primarily through contract manufacturing arrangements that combine engineering and production services:

  • NPI / engineering-related revenue: typically tied to program launches and prototype-to-production transitions.
  • Production manufacturing revenue: ongoing unit-based or program-based billing as customer products scale.
  • Testing, integration, and value-added processes: higher-margin portions when the work requires complexity (system integration, specialized testing, tighter tolerances, controlled documentation).

Margin drivers in EMS commonly include (i) manufacturing efficiency and labor productivity, (ii) utilization of capacity (absorption of fixed costs), (iii) mix shift toward higher value-added assemblies and testing, and (iv) the ability to manage supply chain volatility and component pricing pass-through mechanics. Working capital efficiency (notably inventory turns and payment terms) also influences free cash flow quality.

🧠 Competitive Advantages & Market Positioning

KE’s moat is best characterized by switching costs and quality/regulatory embeddedness, reinforced by operational cost discipline in complex manufacturing.

  • Switching Costs / Program Qualification: Once a supplier is qualified for a product—especially for applications with stringent testing, traceability, and documented process control—re-qualifying a new manufacturer is costly, time-consuming, and risk-laden. That creates inertia in customer supplier selection.
  • Complexity and Process Know-How: Competence in managing high-mix builds, component integration, and robust test processes supports stickier, longer-duration production programs.
  • Quality Systems as an Intangible Asset: Durable compliance capability (including documentation and process control expectations common in regulated end markets) functions as a barrier to entry and reduces customer perceived risk.
  • Cost & Supply Chain Management: Like peers, KE competes through procurement execution, lean manufacturing, and yield management—efforts that become more valuable as customers demand resilient supply chains.

Competitive benchmarking (industry peers):

  • Flex (flex.com), Sanmina (sanmina.com), and Jabil (jabil.com) are large EMS competitors with broad end-market exposure and scale-based advantages.
  • KE typically positions with a focus on complex manufacturing programs and end-market segments where qualification, quality systems, and process execution carry more weight than pure scale.
  • Compared with large peers that may emphasize diversified breadth, KE’s differentiation relies more on manufacturing execution depth and customer-specific integration work that increases switching friction.

🚀 Multi-Year Growth Drivers

Over a five- to ten-year horizon, KE’s addressable opportunity is supported by structural demand for electronics-intensive products and supply chain reconfiguration:

  • Ongoing electronic content growth: Greater digitization and electrification expand unit volumes and drive more sophisticated assemblies (more testing, higher value-added integration).
  • Medical and industrial complexity: Regulated and mission-critical equipment requires disciplined manufacturing, traceability, and validated processes—conditions that favor qualified suppliers.
  • Supply chain reshoring / nearshoring: Customers increasingly prioritize shorter lead times, diversified manufacturing footprints, and reliable execution. This supports new program sourcing and incremental capacity demand.
  • Outsourcing of specialized manufacturing: OEMs often retain design while outsourcing assembly, testing, and lifecycle production execution to EMS partners with proven process control.

⚠ Risk Factors to Monitor

  • Customer and end-market concentration risk: EMS margins are sensitive to volume swings and program ramp timing across major customers and sectors.
  • Margin pressure from utilization and mix: Fixed-cost absorption is a key driver; underutilization can compress operating margins.
  • Technological and component obsolescence: Rapid design changes can require process adjustments, inventory risk, and retooling.
  • Quality and compliance exposure: For regulated applications, quality escapes can trigger warranty costs, customer remediation, and reputational loss that impacts future program wins.
  • Supply chain and logistics disruptions: Component shortages, lead-time volatility, and freight constraints can affect production schedules and working capital.
  • Contracting terms and pass-through mechanics: Where customers cap component or labor cost variability, EMS operators may face margin headwinds.

📊 Valuation & Market View

Equity markets often value EMS businesses on enterprise value to earnings metrics (such as EV/EBITDA) and earnings power rather than on near-term top-line growth alone. The factors that typically move valuation expectations include:

  • Operating margin durability: evidence of sustained manufacturing efficiency and disciplined cost control.
  • Capacity utilization and backlog/program visibility: smoother ramp patterns support more stable earnings.
  • Cash conversion: working capital efficiency and reliable free cash flow generation can command a valuation premium.
  • Quality track record: lower expected remediation and lower program attrition risk.

Because EMS earnings can be cyclical with end-market demand, investors typically price not only current profitability but also the credibility of margin support through cycles.

🔍 Investment Takeaway

KE’s long-term investment case centers on supplier qualification-driven switching costs, process and quality capability embedded in production programs, and cost discipline that supports value creation when utilization and program mix are favorable. In a sector where competitors often compete on scale, KE’s differentiated positioning emphasizes complex manufacturing execution and sustained customer qualification—attributes that can translate into more defensible program retention and earnings resilience over time.


⚠ AI-generated — informational only. Validate using filings before investing.

```

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for KE.

zacks.com2026-06-05

Is the Options Market Predicting a Spike in Kimball Electronics Stock?

Investors need to pay close attention to KE stock based on the movements in the options market lately.

businesswire.com2026-05-19

Kimball Electronics to Participate at the 26th Annual B. Riley Securities Institutional Investor Conference

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced the Company will be attending the 26th Annual B. Riley Securities Institutional Investor Conference, which is being held May 20-21 at the Ritz Carlton Marina Del Rey, CA. Jana Croom, Chief Financial Officer, and Andrew Regrut, Vice President, Investor Relations, Strategic Development, and Treasurer, will be available for one-on-one meetings throughout the conference. For additional information about the confer.

seekingalpha.com2026-05-06

Kimball Electronics, Inc. (KE) Q3 2026 Earnings Call Transcript

Kimball Electronics, Inc. (KE) Q3 2026 Earnings Call Transcript

zacks.com2026-05-05

Kimball Electronics (KE) Q3 Earnings and Revenues Miss Estimates

Kimball Electronics (KE) came out with quarterly earnings of $0.33 per share, missing the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.27 per share a year ago.

businesswire.com2026-05-05

Kimball Electronics Reports Q3 Results With Double-Digit Sequential Medical Sales Growth; Company Affirms Guidance for Fiscal 2026 With Adjusted Operating Margin Expected at High End of Range

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced financial results for the third quarter ended March 31, 2026.                   Three Months Ended   Nine Months Ended   March 31,   March 31, (Amounts in Thousands, except EPS)   2026       2025       2026       2025   Net Sales $ 352,922     $ 374,607     $ 1,059,805     $ 1,106,255   Operating Income $ 11,755     $ 11,716     $ 36,976     $ 29,061   Adjusted Operating Income (non-GAAP) $ 14,781     $ 15,706.

businesswire.com2026-04-22

Kimball Electronics, Inc. Announces Date For Reporting Third Quarter Fiscal Year 2026 Financial Results

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced that it will report third quarter fiscal year 2026 financial results on Tuesday, May 5, 2026, after the closing of the market. The company will host a conference call and live webcast to review the results on Wednesday, May 6, 2026, at 10:00 a.m. Eastern Time. The telephone number to access the conference call is 877-407-8293 / +1 201-689-8349. A live webcast of the conference call can be accessed at investors.

defenseworld.net2026-04-05

Kimball Electronics, Inc. $KE Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase and Co. raised its stake in shares of Kimball Electronics, Inc. (NASDAQ: KE) by 806.4% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 112,710 shares of the electronics maker's stock after acquiring an additional 100,275 shares during

defenseworld.net2026-03-22

Kimball Electronics Maps Medical Pivot, Raises Outlook, Unveils 300,000-Sq-Ft Indianapolis Facility at Forum

Kimball Electronics (NASDAQ: KE) used an appearance at KeyBanc's sixth annual Healthcare Forum to outline how the contract manufacturer is shifting more of its portfolio toward medical end markets, while also providing an update on recent performance and a new Indianapolis facility designed to support expanded medical-device manufacturing. Company background and footprint Chief Financial Officer Jana

businesswire.com2026-03-19

Kimball Electronics Releases 2025 Annual Sustainability Report

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced the release of its 2025 Guiding Principles Report, which includes the company's annual sustainability disclosures. Themed “Building Tomorrow, Together,” the Report outlines progress on environmental, social, and governance (ESG) initiatives and reflects the company's continued focus on the issues that matter most—where it can make a meaningful and lasting difference for people and the environment, while suppor.

businesswire.com2026-03-10

Kimball Electronics to Participate in March Investor Conferences and Host Fireside Discussions

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced its upcoming participation in multiple investor conferences in March 2026, including hosted fireside chats and one-on-one meetings with institutional investors. Cantor Global Technology & Industrial Growth Conference When: Wednesday, March 11, 2026 Location: New York Hilton Midtown, 1335 Avenue of the Americas, New York, NY 10019 Format: Fireside chat (in-person participation only) and one-on-one meetings.

defenseworld.net2026-03-09

Kimball Electronics, Inc. $KE Shares Bought by American Century Companies Inc.

American Century Companies Inc. lifted its holdings in shares of Kimball Electronics, Inc. (NASDAQ: KE) by 19.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 837,443 shares of the electronics maker's stock after buying an additional 139,029 shares

defenseworld.net2026-03-09

Reviewing Kimball Electronics (NASDAQ:KE) & The Coretec Group (OTCMKTS:CRTG)

Kimball Electronics (NASDAQ: KE - Get Free Report) and The Coretec Group (OTCMKTS:CRTG - Get Free Report) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, risk and dividends. Risk and Volatility Kimball

defenseworld.net2026-02-24

Counterpoint Mutual Funds LLC Invests $2.34 Million in Kimball Electronics, Inc. $KE

Counterpoint Mutual Funds LLC acquired a new stake in Kimball Electronics, Inc. (NASDAQ: KE) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 78,267 shares of the electronics maker's stock, valued at approximately $2,337,000. Counterpoint Mutual Funds LLC owned about

defenseworld.net2026-02-19

Principal Financial Group Inc. Purchases New Shares in Kimball Electronics, Inc. $KE

Principal Financial Group Inc. acquired a new position in Kimball Electronics, Inc. (NASDAQ: KE) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 30,577 shares of the electronics maker's stock, valued at approximately $913,000. Principal Financial Group Inc. owned approximately 0.13%

defenseworld.net2026-02-18

LSV Asset Management Trims Holdings in Kimball Electronics, Inc. $KE

LSV Asset Management lowered its holdings in Kimball Electronics, Inc. (NASDAQ: KE) by 90.6% in the undefined quarter, according to the company in its most recent filing with the SEC. The firm owned 16,900 shares of the electronics maker's stock after selling 162,123 shares during the quarter. LSV Asset Management owned approximately 0.07%

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"KE reported Q3’26 revenue of $352.9M and net income of $5.72M (EPS $0.23). YoY (vs Q3’25) revenue declined to $374.6M (-5.8% YoY) while net income fell from $3.82M to $5.72M (+49.9% YoY). QoQ (vs Q2’26) revenue rose to $341.3M (+3.4% QoQ) and net income increased from $3.64M to $5.72M (+57.4% QoQ). Profitability improved: net margin expanded to 1.62% from 1.07% QoQ and 1.02% YoY, while operating margin rose to 3.33% from 3.81% QoQ (slight QoQ operating compression) but remained above Q3’25 levels. Cash flow quality was mixed but ended positively. Operating cash flow was $14.9M in Q3’26, up from $6.9M in Q2’26, and the quarter generated $14.9M free cash flow, supported by working-capital inflows. Balance sheet resilience looks stronger: total assets increased to $1.10B while cash and equivalents rose to $82.5M and leverage remains low (net debt of about -$82.5M, i.e., net cash). Shareholder returns are strong on momentum: the stock is up +104.7% over 1 year, with no stated dividend (0% yield in provided data) and modest buybacks (repurchased $5.63M of stock this quarter)."

Revenue Growth

Positive

Revenue was +3.4% QoQ (to $352.9M) but -5.8% YoY (vs $374.6M). Near-term stabilization, but longer YoY contraction.

Profitability

Good

Net income +57.4% QoQ and +49.9% YoY; net margin improved to 1.62% from 1.07% QoQ and 1.02% YoY. Operating margin was 3.33% vs 3.81% QoQ (slight QoQ operating pressure) but stronger than Q3’25.

Cash Flow Quality

Good

Operating cash flow $14.9M and free cash flow $14.9M in Q3’26, improving from Q2’26 OCF of $6.9M. Cash conversion appears supported by working capital; dividend is $0.

Leverage & Balance Sheet

Strong

Total assets rose to $1.10B. Liquidity improved with cash up to $82.5M. Leverage is low with net cash position (net debt about -$82.5M), and equity is not impaired in the latest quarter’s presentation.

Shareholder Returns

Strong

Strong total value momentum: +104.7% 1Y price change. Dividend yield is 0%, but the company repurchased ~$5.63M shares in the quarter, supporting capital appreciation.

Analyst Sentiment & Valuation

Neutral

Price ~$26.81 vs consensus target ~$32 implies upside (~19%). However, provided valuation multiples suggest a relatively rich earnings yield profile, limiting the score.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Kimball Electronics reported Q3 FY26 results broadly in line, with sequential sales up 3.4% and Medical again leading. Reported YoY sales declined due to a prior-year nonrecurring Medical consigned inventory sale, but normalized comparisons show total sales up ~1% and Medical up ~17%, marking the third straight quarter of double-digit Medical growth. Gross margin rose 70 bps to 7.9% despite ongoing Medical CMO ramp, while adjusted diluted EPS increased to $0.33. Cash flow remained strong with positive operating cash flow for the ninth consecutive quarter and improving cash conversion days. Guidance was affirmed, calling for FY26 revenue of $1.4B–$1.46B and adjusted operating margin at the high end of 4.2%–4.5%, implying Q4 revenue $370M–$380M. The main margin risk is the Indianapolis facility ramp, expected to pressure FY27 gross margin by 40–50 bps before abating in FY28. Automotive demand risk is tied to macro/EV incentive volatility, while Industrial faces HVAC softness.

AI IconGrowth Catalysts

  • Medical vertical sequential and normalized year-over-year growth led by respiratory care, imaging systems, drug delivery devices, and blood separation products
  • Medical CMO volume ramp in Indianapolis expected to drive both top-line growth and margin expansion with a stated 18–36 month program path
  • Automotive Poland and Romania steering/braking ramp: combined up 20% in-quarter with expected continuation through balance of 2026

Business Development

  • Medical CMO strategy targeting “lift-and-shift” programs (customers shifting existing manufacturing into Kimball capacity)
  • Target goal: add 5 new Medical customers annually (management stated FY26 is on track)
  • Active M&A evaluation focused on Medical CMO tuck-ins for capabilities (micro-molding, advanced precision injection, high-automation engineering) and U.S. geographic footprint expansion

AI IconFinancial Highlights

  • Net sales: $352.9M in Q3 FY26; +3.4% sequential; -6% YoY reported due to prior-year $24M nonrecurring consigned inventory sale in Medical (normalized: total sales +~1% YoY; Medical +17% YoY)
  • Medical growth: +10% YoY reported; +17% YoY normalized; third consecutive quarter of double-digit Medical growth; Q3 Medical sales $106M (30% of total company)
  • Gross margin: 7.9% in Q3, +70 bps vs 7.2% in Q3 FY25 (mix and easier comparison vs prior-year inventory sale; offset by Medical CMO ramp)
  • Adjusted operating income: $14.8M, 4.2% of net sales (vs $15.7M, 4.2% of net sales prior year—lower dollars but same rate)
  • Adjusted diluted EPS: $0.33 vs $0.27 prior year; adjusted net income $8.0M
  • Selling & admin: 3.7% of sales vs 3.0% prior year (13.0M; +$1.8M YoY); management cited FY26 transformation/IT and business development investment
  • Tax rate: 34.9% in Q3 vs 46.6% in Q3 FY25; FY26 expected ~30% (explanation: prior year interest deductibility limitation)
  • Cash flow: operating cash flow +$14.9M (9th consecutive quarter positive); cash conversion days 90 (improved +1 vs prior quarter; +9 vs Q3 FY25)

AI IconCapital Funding

  • Cash and cash equivalents: $82.5M at March 31, 2026
  • Borrowings: $163M at March 31, 2026 (down ~9% YoY; +$8.8M vs Q2)
  • Unused liquidity: $358.5M total dry powder (cash + unused credit facilities); revolver renewed $300M in April
  • Share repurchase: $4.0M in Q3; 165,000 shares; $6.5M remaining under repurchase program; $113.5M returned since Oct 2015 (7.0M shares)
  • CapEx: $14.4M in Q3; full-year guidance $50M–$60M

AI IconStrategy & Ops

  • Indianapolis manufacturing facility: ~300,000 sq ft; clean rooms installing; expected to begin production by end of calendar year; moving existing Indianapolis production plus new programs
  • CMO facility margin headwind: expected 40–50 bps gross margin impact in FY27 due to ramp costs while current facility still operates; abate in FY28 as utilization increases
  • Inventory reduction: $273.3M end of quarter; down $8.4M vs Q2; down $23.3M (-8%) YoY; CCD improvement attributed to tighter component management/supply chain working capital control (not revenue)

AI IconMarket Outlook

  • Affirmed FY26 guidance: revenue range $1.4B–$1.46B; adjusted operating income margin expected at high end of 4.2%–4.5%
  • Implied Q4: revenue $370M–$380M; adjusted OI margin 4.4%–4.6%
  • Q4 expected to be sequential sales increase with Medical growth outpacing other verticals
  • Monitor macro impacts: war in Iran (higher freight/raw material costs), higher U.S. gas prices, consumer sentiment; Automotive demand affected by EV electronic steering demand and legislative impacts on EV incentives

AI IconRisks & Headwinds

  • Medical CMO ramp timeline risk: management reiterated 18–36 months to CMO revenue; margins face near-term pressure during facility ramp
  • FY27 gross margin risk: 40–50 bps headwind expected from Indianapolis facility ramp
  • Automotive demand volatility risk: reduced EV program demand in North America tied to legislative changes affecting consumer incentives; demand is fluid with U.S. gasoline price changes
  • Industrial headwind: HVAC demand lower in North America; possible near-term impact to green energy/Off-highway/public safety adjacent areas from protracted war in Middle East
  • CMO competitive pricing risk: pricing described as competitive but “rational”; management did not cite irrational pricing, but competition remains a factor

Q&A: Analyst Interest

  • Indianapolis facility ramp economics: Management described ongoing clean-room buildout and approvals, production starting by end of calendar year, and FY27 gross margin headwind of 40–50 bps. They emphasized both “existing program moves” and “new programs” plus lift-and-shift while current facility continues operating.
  • Medical capacity bookings and dependence on new logos: Management said they’re early to quantify booked capacity because the Indianapolis facility is leased and space is reserved for growth. They confirmed a strategy to add new logos to attract capacity-based demand, while existing customers remain active in program discussions.
  • Medical competitive/pricing environment and M&A appetite: Management stated CMO/CDMO pricing is always competitive but “still rational” and supported by supply-chain capacity needs in medical. They highlighted evaluation criteria for Medical CMO tuck-ins for capabilities and U.S. footprint, stating they can act decisively given cash generation and debt comfort.

Sentiment: MIXED

Note: This summary was synthesized by AI from the KE Q3 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for KE.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (KE)

© 2026 Stock Market Info — Kimball Electronics, Inc. (KE) Financial Profile